About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

FLU A+B Nasal Swab Clinical Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00636662

FLU A+B Nasal Swab Clinical Study

The purpose of this clinical study is to obtain clearance for the nasal swab sample type by demonstrating the performance characteristics of the FLU A+B Test versus standard laboratory culture for Inf...

Lead sponsor: Response Biomedical Corp.•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Response Biomedical Corp.

Patients exhibiting symptoms of influenza enrolled in a fashion that confidentiality of all personal health information is maintained. No patient treatment is affected by enrollment in this trial.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male and Female of all age groups
•Patients exhibiting influenza symptoms (i.e., fever, body aches, headaches, cough, sore throat, and other respiratory symptoms) at the time of examination
•Patients must either present with a fever (\>100ºF; \>37.8ºC) at time of examination or have had a fever (\>100ºF; \>37.8ºC) or declare at time of the examination that they had a fever within the previous 3 days prior to the examination
•Must be able to collect sample using the nasal swab sample type

Exclusion Criteria

•Patients with no fever at time of examination or within the 3 days prior to examination and/or are currently undergoing treatment (including anti-virals) will be excluded from the study.

Related studies

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

NCT01386424 · Zika, Influenza

RECRUITINGPhase 1

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

NCT07169318 · Influenza

RECRUITINGPhase 1/2

Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

NCT07291635 · Influenza

RECRUITINGPhase 2

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

NCT06599658 · COVID 19, Influenza, and more

RECRUITINGPhase 3

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

NCT06094010 · Influenza

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 27, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment800

Start dateFeb 2008

Last updatedMar 27, 2019

Condition

Locations shown

Northwestern University

Chicago, Illinois

Washington University / St. Louis Children's Hospital

St Louis, Missouri

Wake Forest University Health Sciences

Winston-Salem, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions